KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Year-over-year debt growth rate
Latest
2335.84%
↑ 1605% vs avg
Percentile
P97
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
137.03%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 2335.84% |
| Q3 2025 | -2.63% |
| Q2 2025 | 9.08% |
| Q1 2025 | -6.92% |
| Q4 2024 | -0.64% |
| Q3 2024 | -14.56% |
| Q2 2024 | -1.71% |
| Q1 2024 | -3.25% |
| Q4 2023 | -3.67% |
| Q3 2023 | -2.98% |
| Q2 2023 | -2.90% |
| Q1 2023 | -2.90% |
| Q4 2022 | -3.11% |
| Q3 2022 | 10.05% |
| Q2 2022 | -3.45% |
| Q1 2022 | 18.55% |
| Q4 2021 | -3.05% |
| Q3 2021 | 24.88% |
| Q2 2021 | 244.55% |
| Q1 2021 | 26.66% |
| Q4 2020 | -11.10% |
| Q3 2020 | -7.42% |
| Q2 2020 | 8.37% |
| Q1 2020 | -8.28% |
| Q4 2019 | -5.81% |
| Q3 2019 | 3153.70% |
| Q2 2019 | -50.46% |
| Q1 2019 | -30.57% |
| Q4 2018 | -26.64% |
| Q3 2018 | -23.30% |
| Q2 2018 | -17.70% |
| Q1 2018 | -8.13% |
| Q4 2017 | -11.08% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | 0.91% |
| Q4 2015 | 0.94% |